Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Single positive core prostate cancer in a 12-core transrectal biopsy scheme: Clinicopathological implications compared with multifocal counterpart

Full metadata record
DC Field Value Language
dc.contributor.authorAhn, H.J.-
dc.contributor.authorKo, Y.H.-
dc.contributor.authorJang, H.A.-
dc.contributor.authorKang, S.G.-
dc.contributor.authorKang, S.H.-
dc.contributor.authorPark, H.S.-
dc.contributor.authorLee, J.G.-
dc.contributor.authorKim, J.J.-
dc.contributor.authorCheon, J.-
dc.date.accessioned2021-09-08T09:05:14Z-
dc.date.available2021-09-08T09:05:14Z-
dc.date.created2021-06-17-
dc.date.issued2010-
dc.identifier.issn2005-6737-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/118267-
dc.description.abstractPurpose: The incidence of single positive core prostate cancer at the time of biopsy appears to be increasing in the prostate-specific antigen (PSA) era. To determine the clinical implication of this disease, we analyzed surgical and pathological characteristics in comparison with multiple positive core disease. Materials and Methods: Among 108 consecutive patients who underwent robotic radical prostatectomy following a diagnosis of prostate cancer based on a 12-core transrectal biopsy performed by the same method in a single institute, outcomes from 26 patients (Group 1) diagnosed on the basis of a single positive biopsy core and from 82 patients (Group 2) with multiple positive biopsy cores were analyzed. Results: The preoperative PSA value, Gleason score, prostate volume, and D'Amico's risk classification of each group were similar. The proportion of intermediate + high-risk patients was 69.2% in Group 1 and 77.9% in Group 2 (p=0.22). Total operative time and blood loss were similar. Based on prostatectomy specimens, only 3 patients (11.5%) in Group 1 met the criteria for an indolent tumor (7.31% in Group 2). Although similarities were observed during preoperative clinical staging (p=0.13), the final pathologic stage was significantly higher in Group 2 (p=0.001). The positive-margin rate was also higher in Group 2 (11.5% vs. 31.7%, p=0.043). Despite similarity in upstaging after prostatectomy in each group (p=0.86), upgrading occurred more frequently in Group 1 (p=0.014, 42.5% vs. 19.5%). No clinical parameters were valuable in predicting upgrading. Conclusions: Most single positive core prostate cancer diagnoses in 12-core biopsy were clinically significant with similar risk stratification to multiple positive core prostate cancers. Although the positive-margin rate was lower than in multiple positive core disease, an increase in Gleason score after radical prostatectomy occurred more frequently. © The Korean Urological Association, 2010.-
dc.languageEnglish-
dc.language.isoen-
dc.subjectprostate specific antigen-
dc.subjectadult-
dc.subjectarticle-
dc.subjectbiopsy technique-
dc.subjectcancer grading-
dc.subjectcancer risk-
dc.subjectcancer staging-
dc.subjectcontrolled study-
dc.subjectGleason score-
dc.subjecthuman-
dc.subjecthuman tissue-
dc.subjectintermethod comparison-
dc.subjectmajor clinical study-
dc.subjectmale-
dc.subjectneedle biopsy-
dc.subjectoperation duration-
dc.subjectpostoperative period-
dc.subjectpreoperative evaluation-
dc.subjectpreoperative period-
dc.subjectprostate adenocarcinoma-
dc.subjectprostate biopsy-
dc.subjectprostatectomy-
dc.subjectrisk assessment-
dc.subjectrobotics-
dc.subjecttransrectal ultrasonography-
dc.titleSingle positive core prostate cancer in a 12-core transrectal biopsy scheme: Clinicopathological implications compared with multifocal counterpart-
dc.typeArticle-
dc.contributor.affiliatedAuthorKo, Y.H.-
dc.contributor.affiliatedAuthorKang, S.G.-
dc.contributor.affiliatedAuthorKang, S.H.-
dc.contributor.affiliatedAuthorPark, H.S.-
dc.contributor.affiliatedAuthorLee, J.G.-
dc.contributor.affiliatedAuthorKim, J.J.-
dc.contributor.affiliatedAuthorCheon, J.-
dc.identifier.doi10.4111/kju.2010.51.10.671-
dc.identifier.scopusid2-s2.0-78149301233-
dc.identifier.bibliographicCitationKorean Journal of Urology, v.51, no.10, pp.671 - 676-
dc.relation.isPartOfKorean Journal of Urology-
dc.citation.titleKorean Journal of Urology-
dc.citation.volume51-
dc.citation.number10-
dc.citation.startPage671-
dc.citation.endPage676-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.identifier.kciidART001489189-
dc.description.journalClass1-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.subject.keywordPlusprostate specific antigen-
dc.subject.keywordPlusadult-
dc.subject.keywordPlusarticle-
dc.subject.keywordPlusbiopsy technique-
dc.subject.keywordPluscancer grading-
dc.subject.keywordPluscancer risk-
dc.subject.keywordPluscancer staging-
dc.subject.keywordPluscontrolled study-
dc.subject.keywordPlusGleason score-
dc.subject.keywordPlushuman-
dc.subject.keywordPlushuman tissue-
dc.subject.keywordPlusintermethod comparison-
dc.subject.keywordPlusmajor clinical study-
dc.subject.keywordPlusmale-
dc.subject.keywordPlusneedle biopsy-
dc.subject.keywordPlusoperation duration-
dc.subject.keywordPluspostoperative period-
dc.subject.keywordPluspreoperative evaluation-
dc.subject.keywordPluspreoperative period-
dc.subject.keywordPlusprostate adenocarcinoma-
dc.subject.keywordPlusprostate biopsy-
dc.subject.keywordPlusprostatectomy-
dc.subject.keywordPlusrisk assessment-
dc.subject.keywordPlusrobotics-
dc.subject.keywordPlustransrectal ultrasonography-
dc.subject.keywordAuthorBiopsy-
dc.subject.keywordAuthorProstatectomy-
dc.subject.keywordAuthorProstatic neoplasms-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kang, Seok Ho photo

Kang, Seok Ho
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE